Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 45% ± 15% | |
peripheral blood | 17 studies | 33% ± 10% | |
brain | 11 studies | 29% ± 12% | |
intestine | 8 studies | 39% ± 19% | |
kidney | 8 studies | 37% ± 11% | |
liver | 7 studies | 36% ± 14% | |
heart | 5 studies | 33% ± 9% | |
pancreas | 4 studies | 61% ± 17% | |
bone marrow | 4 studies | 36% ± 14% | |
eye | 4 studies | 28% ± 12% | |
uterus | 4 studies | 67% ± 10% | |
breast | 4 studies | 46% ± 13% | |
prostate | 4 studies | 44% ± 15% | |
adipose | 4 studies | 40% ± 15% | |
placenta | 3 studies | 72% ± 14% | |
lymph node | 3 studies | 28% ± 8% | |
skin | 3 studies | 31% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 21877.20 | 576 / 578 | 100% | 87.64 | 1150 / 1155 |
intestine | 99% | 20056.96 | 957 / 966 | 98% | 70.54 | 519 / 527 |
breast | 100% | 22668.33 | 459 / 459 | 97% | 100.25 | 1089 / 1118 |
bladder | 100% | 19442.00 | 21 / 21 | 94% | 64.63 | 474 / 504 |
uterus | 100% | 23726.57 | 170 / 170 | 90% | 63.70 | 415 / 459 |
esophagus | 90% | 25037.78 | 1297 / 1445 | 100% | 92.34 | 183 / 183 |
thymus | 98% | 11544.09 | 643 / 653 | 89% | 48.47 | 538 / 605 |
ovary | 93% | 12125.06 | 168 / 180 | 91% | 44.78 | 393 / 430 |
adrenal gland | 90% | 10201.23 | 232 / 258 | 89% | 56.99 | 204 / 230 |
stomach | 80% | 13131.96 | 288 / 359 | 98% | 77.56 | 280 / 286 |
skin | 87% | 32231.24 | 1565 / 1809 | 91% | 71.99 | 431 / 472 |
prostate | 83% | 11825.86 | 204 / 245 | 92% | 51.68 | 460 / 502 |
kidney | 75% | 7551.28 | 67 / 89 | 91% | 84.34 | 824 / 901 |
pancreas | 60% | 4565.74 | 196 / 328 | 97% | 118.97 | 173 / 178 |
liver | 53% | 5016.01 | 120 / 226 | 83% | 54.92 | 337 / 406 |
adipose | 100% | 27891.72 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 55768.37 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.56 | 1 / 1 |
muscle | 95% | 9893.82 | 760 / 803 | 0% | 0 | 0 / 0 |
brain | 20% | 1479.93 | 531 / 2642 | 72% | 24.00 | 505 / 705 |
heart | 91% | 17262.21 | 785 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 56.92 | 41 / 45 |
spleen | 90% | 8879.57 | 216 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 74% | 24.61 | 59 / 80 |
lymph node | 0% | 0 | 0 / 0 | 45% | 15.65 | 13 / 29 |
peripheral blood | 21% | 1507.68 | 199 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002052 | Biological process | positive regulation of neuroblast proliferation |
GO_0031623 | Biological process | receptor internalization |
GO_0033627 | Biological process | cell adhesion mediated by integrin |
GO_0006909 | Biological process | phagocytosis |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0030183 | Biological process | B cell differentiation |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0035024 | Biological process | negative regulation of Rho protein signal transduction |
GO_0023035 | Biological process | CD40 signaling pathway |
GO_0001701 | Biological process | in utero embryonic development |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0150103 | Biological process | reactive gliosis |
GO_0060912 | Biological process | cardiac cell fate specification |
GO_0010763 | Biological process | positive regulation of fibroblast migration |
GO_0000132 | Biological process | establishment of mitotic spindle orientation |
GO_2000811 | Biological process | negative regulation of anoikis |
GO_0007155 | Biological process | cell adhesion |
GO_0034113 | Biological process | heterotypic cell-cell adhesion |
GO_1901979 | Biological process | regulation of inward rectifier potassium channel activity |
GO_0030030 | Biological process | cell projection organization |
GO_1900748 | Biological process | positive regulation of vascular endothelial growth factor signaling pathway |
GO_0008542 | Biological process | visual learning |
GO_0071711 | Biological process | basement membrane organization |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0048626 | Biological process | myoblast fate specification |
GO_0050901 | Biological process | leukocyte tethering or rolling |
GO_0045214 | Biological process | sarcomere organization |
GO_0045906 | Biological process | negative regulation of vasoconstriction |
GO_0035313 | Biological process | wound healing, spreading of epidermal cells |
GO_0007405 | Biological process | neuroblast proliferation |
GO_1905806 | Biological process | regulation of synapse pruning |
GO_0033631 | Biological process | cell-cell adhesion mediated by integrin |
GO_0048813 | Biological process | dendrite morphogenesis |
GO_0048333 | Biological process | mesodermal cell differentiation |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0060379 | Biological process | cardiac muscle cell myoblast differentiation |
GO_0045445 | Biological process | myoblast differentiation |
GO_0007517 | Biological process | muscle organ development |
GO_0021943 | Biological process | formation of radial glial scaffolds |
GO_0048675 | Biological process | axon extension |
GO_0010710 | Biological process | regulation of collagen catabolic process |
GO_0007520 | Biological process | myoblast fusion |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0016477 | Biological process | cell migration |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0051951 | Biological process | positive regulation of glutamate uptake involved in transmission of nerve impulse |
GO_0031589 | Biological process | cell-substrate adhesion |
GO_0055007 | Biological process | cardiac muscle cell differentiation |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_0030032 | Biological process | lamellipodium assembly |
GO_0002042 | Biological process | cell migration involved in sprouting angiogenesis |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0006968 | Biological process | cellular defense response |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0071404 | Biological process | cellular response to low-density lipoprotein particle stimulus |
GO_0045665 | Biological process | negative regulation of neuron differentiation |
GO_0045743 | Biological process | positive regulation of fibroblast growth factor receptor signaling pathway |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0035633 | Biological process | maintenance of blood-brain barrier |
GO_0150003 | Biological process | regulation of spontaneous synaptic transmission |
GO_0043149 | Biological process | stress fiber assembly |
GO_0008354 | Biological process | germ cell migration |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0007161 | Biological process | calcium-independent cell-matrix adhesion |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0007159 | Biological process | leukocyte cell-cell adhesion |
GO_0090303 | Biological process | positive regulation of wound healing |
GO_0034674 | Cellular component | integrin alpha5-beta1 complex |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0045121 | Cellular component | membrane raft |
GO_0034666 | Cellular component | integrin alpha2-beta1 complex |
GO_0034679 | Cellular component | integrin alpha9-beta1 complex |
GO_0008305 | Cellular component | integrin complex |
GO_0034665 | Cellular component | integrin alpha1-beta1 complex |
GO_0009986 | Cellular component | cell surface |
GO_0035748 | Cellular component | myelin sheath abaxonal region |
GO_0010008 | Cellular component | endosome membrane |
GO_0034677 | Cellular component | integrin alpha7-beta1 complex |
GO_0034667 | Cellular component | integrin alpha3-beta1 complex |
GO_0150053 | Cellular component | cerebellar climbing fiber to Purkinje cell synapse |
GO_0034668 | Cellular component | integrin alpha4-beta1 complex |
GO_0001726 | Cellular component | ruffle |
GO_0097060 | Cellular component | synaptic membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0030175 | Cellular component | filopodium |
GO_0030027 | Cellular component | lamellipodium |
GO_0034682 | Cellular component | integrin alphav-beta1 complex |
GO_0014704 | Cellular component | intercalated disc |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0034681 | Cellular component | integrin alpha11-beta1 complex |
GO_0016020 | Cellular component | membrane |
GO_0055037 | Cellular component | recycling endosome |
GO_0034675 | Cellular component | integrin alpha6-beta1 complex |
GO_0034678 | Cellular component | integrin alpha8-beta1 complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0097386 | Cellular component | glial cell projection |
GO_0032587 | Cellular component | ruffle membrane |
GO_0034680 | Cellular component | integrin alpha10-beta1 complex |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0043197 | Cellular component | dendritic spine |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0042383 | Cellular component | sarcolemma |
GO_0005925 | Cellular component | focal adhesion |
GO_0045202 | Cellular component | synapse |
GO_0032154 | Cellular component | cleavage furrow |
GO_0042470 | Cellular component | melanosome |
GO_0001618 | Molecular function | virus receptor activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0015026 | Molecular function | coreceptor activity |
GO_0098639 | Molecular function | collagen binding involved in cell-matrix adhesion |
GO_0050839 | Molecular function | cell adhesion molecule binding |
GO_0043236 | Molecular function | laminin binding |
GO_0003779 | Molecular function | actin binding |
GO_0019960 | Molecular function | C-X3-C chemokine binding |
GO_0001968 | Molecular function | fibronectin binding |
GO_1990782 | Molecular function | protein tyrosine kinase binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0002020 | Molecular function | protease binding |
GO_0005515 | Molecular function | protein binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005178 | Molecular function | integrin binding |
GO_0098640 | Molecular function | integrin binding involved in cell-matrix adhesion |
Gene name | ITGB1 |
Protein name | Integrin beta-1 Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29) Integrin beta Integrin subunit beta 1 |
Synonyms | MDF2 FNRB MSK12 |
Description | FUNCTION: Integrins alpha-1/beta-1, alpha-2/beta-1, alpha-10/beta-1 and alpha-11/beta-1 are receptors for collagen. Integrins alpha-1/beta-1 and alpha-2/beta-2 recognize the proline-hydroxylated sequence G-F-P-G-E-R in collagen. Integrins alpha-2/beta-1, alpha-3/beta-1, alpha-4/beta-1, alpha-5/beta-1, alpha-8/beta-1, alpha-10/beta-1, alpha-11/beta-1 and alpha-V/beta-1 are receptors for fibronectin. Alpha-4/beta-1 recognizes one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. Integrin alpha-5/beta-1 is a receptor for fibrinogen. Integrin alpha-1/beta-1, alpha-2/beta-1, alpha-6/beta-1 and alpha-7/beta-1 are receptors for lamimin. Integrin alpha-6/beta-1 (ITGA6:ITGB1) is present in oocytes and is involved in sperm-egg fusion (By similarity). Integrin alpha-4/beta-1 is a receptor for VCAM1. It recognizes the sequence Q-I-D-S in VCAM1. Integrin alpha-9/beta-1 is a receptor for VCAM1, cytotactin and osteopontin. It recognizes the sequence A-E-I-D-G-I-E-L in cytotactin. Integrin alpha-3/beta-1 is a receptor for epiligrin, thrombospondin and CSPG4. Alpha-3/beta-1 may mediate with LGALS3 the stimulation by CSPG4 of endothelial cells migration. Integrin alpha-V/beta-1 is a receptor for vitronectin. Beta-1 integrins recognize the sequence R-G-D in a wide array of ligands. When associated with alpha-7 integrin, regulates cell adhesion and laminin matrix deposition. Involved in promoting endothelial cell motility and angiogenesis. Involved in osteoblast compaction through the fibronectin fibrillogenesis cell-mediated matrix assembly process and the formation of mineralized bone nodules. May be involved in up-regulation of the activity of kinases such as PKC via binding to KRT1. Together with KRT1 and RACK1, serves as a platform for SRC activation or inactivation. Plays a mechanistic adhesive role during telophase, required for the successful completion of cytokinesis. Integrin alpha-3/beta-1 provides a docking site for FAP (seprase) at invadopodia plasma membranes in a collagen-dependent manner and hence may participate in the adhesion, formation of invadopodia and matrix degradation processes, promoting cell invasion. ITGA4:ITGB1 binds to fractalkine (CX3CL1) and may act as its coreceptor in CX3CR1-dependent fractalkine signaling . ITGA4:ITGB1 and ITGA5:ITGB1 bind to PLA2G2A via a site (site 2) which is distinct from the classical ligand-binding site (site 1) and this induces integrin conformational changes and enhanced ligand binding to site 1 . ITGA5:ITGB1 acts as a receptor for fibrillin-1 (FBN1) and mediates R-G-D-dependent cell adhesion to FBN1 . ITGA5:ITGB1 acts as a receptor for fibronectin FN1 and mediates R-G-D-dependent cell adhesion to FN1 . ITGA5:ITGB1 is a receptor for IL1B and binding is essential for IL1B signaling . ITGA5:ITGB3 is a receptor for soluble CD40LG and is required for CD40/CD40LG signaling . Plays an important role in myoblast differentiation and fusion during skeletal myogenesis (By similarity). ITGA9:ITGB1 may play a crucial role in SVEP1/polydom-mediated myoblast cell adhesion (By similarity). Integrins ITGA9:ITGB1 and ITGA4:ITGB1 repress PRKCA-mediated L-type voltage-gated channel Ca(2+) influx and ROCK-mediated calcium sensitivity in vascular smooth muscle cells via their interaction with SVEP1, thereby inhibit vasocontraction . .; FUNCTION: [Isoform 2]: Interferes with isoform 1 resulting in a dominant negative effect on cell adhesion and migration (in vitro). .; FUNCTION: [Isoform 5]: Isoform 5 displaces isoform 1 in striated muscles. .; FUNCTION: (Microbial infection) Integrin ITGA2:ITGB1 acts as a receptor for Human echoviruses 1 and 8. .; FUNCTION: (Microbial infection) Acts as a receptor for Cytomegalovirus/HHV-5. .; FUNCTION: (Microbial infection) Acts as a receptor for Epstein-Barr virus/HHV-4. .; FUNCTION: (Microbial infection) Integrin ITGA5:ITGB1 acts as a receptor for Human parvovirus B19. .; FUNCTION: (Microbial infection) Integrin ITGA2:ITGB1 acts as a receptor for Human rotavirus. .; FUNCTION: (Microbial infection) Acts as a receptor for Mammalian reovirus. .; FUNCTION: (Microbial infection) In case of HIV-1 infection, integrin ITGA5:ITGB1 binding to extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. .; FUNCTION: (Microbial infection) Interacts with CotH proteins expressed by fungi of the order mucorales, the causative agent of mucormycosis, which plays an important role in epithelial cell invasion by the fungi . Integrin ITGA3:ITGB1 may act as a receptor for R.delemar CotH7 in alveolar epithelial cells, which may be an early step in pulmonary mucormycosis disease progression . .; FUNCTION: (Microbial infection) May serve as a receptor for adhesin A (nadA) of N.meningitidis. . |
Accessions | ENST00000437302.6 [P05556-1] Q5T3E4 ENST00000534049.5 ENST00000474568.6 ENST00000423113.6 [P05556-5] ENST00000488494.6 ENST00000677999.1 [P05556-1] A0A7I2V2T4 ENST00000480226.5 ENST00000678766.1 [P05556-3] ENST00000396033.6 [P05556-1] A0A7I2V348 C9JNE0 ENST00000472147.1 ENST00000488427.2 ENST00000678591.1 ENST00000417122.7 [P05556-1] ENST00000679187.1 ENST00000437302 ENST00000677363.1 ENST00000528877.5 ENST00000676895.1 A0A7I2V2F9 ENST00000676964.1 ENST00000302278.8 [P05556-1] ENST00000414670.2 E9PLR6 Q5T3E5 ENST00000676460.1 [P05556-2] ENST00000678120.1 Q5T3E6 E7EUI6 ENST00000609742.3 ENST00000678989.1 [P05556-1] E7EQW5 H7C4K3 ENST00000678952.1 [P05556-1] ENST00000678701.1 [P05556-1] ENST00000677310.1 [P05556-3] ENST00000494395.1 A0A7I2V5T3 ENST00000417122 C9JPK5 P05556 ENST00000676659.1 [P05556-4] E9PQJ2 H7C4N8 ENST00000678479.1 ENST00000678943.1 [P05556-1] A0A7I2V5Z8 |